Filter by: patients
Home > Community Treatment Reports and Side Effects > DHE 45 Injectable Treatment Report
What is DHE 45 Injectable?

DHE-45 (dihydroergotamine mesylate, USP) injectable is for the acute treatment of migraine with or without aura.

Reported Purpose & Efficacy

Reasons and Efficacy
Purpose # of patients
# of patients with evaluations Efficacy
Major
Moderate
Slight
None
Can’t tell
Head pain, migraines 2 0
Migraine headaches 2 0
Other 1 0
Migraine 1 0

See all 5 patients currently taking DHE 45 Injectable

Mouse over the table for more information

Reported Dosages

  5mg as needed 2ml as needed 3mg as needed 1mg as needed
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 2 Number of Patients: 2  

Reported Stop Reasons

Why Patients Stopped Taking DHE 45 Injectable (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 1   Doctor's advice: 100%

See all 1 patient who’ve stopped taking DHE 45 Injectable

Reported Duration See details about how long patients take this treatment ▼

Currently Taking DHE 45 Injectable

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Stopped Taking DHE 45 Injectable

A bar graph

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
0
0
0
0

Report created on February 11, 2012.